Riddle, M. C., Bolli, G. B., Home, P. D., Bergenstal, R. M., Ziemen, M., Muehlen-Bartmer, I., . . . Yki-Järvinen, H. (2016). Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes. Diabetes Technol Ther.
Chicago Style aipamenaRiddle, Matthew C., et al. "Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People With Type 2 Diabetes." Diabetes Technol Ther 2016.
MLA aipamenaRiddle, Matthew C., et al. "Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People With Type 2 Diabetes." Diabetes Technol Ther 2016.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.